74 reports

  • RIDTS FOR INFLUENZA B
  • Identifying factors impacting market growth

You can easily book an appointment with one online.

  • Influenza
  • World
  • Forecast
  • Alere Inc.
  • Quidel Corporation
  • Global influenza diagnostics market segmentation by end-users 2015
  • Impact of drivers

About Influenza Diagnostics The global influenza diagnostics market is expected to grow at a moderate pace in the forecast period. The factors that are expected to drive the market in the forecast period includes endemic and pandemic outburst of influenza disease, new strains and lineages in the viruses due to genetic modification...

  • Influenza
  • World
  • Alere Inc.
  • bioMerieux S.A.
  • Quidel Corporation
  • V. COLD AND FLU DRUGS MARKET OUTLOOK
  • V. COLD AND FLU DRUGS MARKET OUTLOOK

China’s demand for Cold and Flu Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption...

  • Influenza
  • China
  • Sanshine Pharmaceutical Co., Ltd.
  • Tongrentang Group
  • Topsun Technology Qidong Gantianli Pharmaceutical Co., Ltd

Type CSL: KEY CUSTOMERS END-USERS HOSPITALS, PHARMACIES, AND HEALTH CENTERS Examples FLUVIRIN is an inactivated vaccine for influenza virus.

  • Influenza
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Sanofi S.A.
  • Seqirus UK Limited
  • Inclusion in NIP

About the H1N1 Vaccines Market The high level of maturity in the H1N1 vaccines market has renewed the push to develop quadrivalent vaccines that address areas of the market with unmet medical needs. Vaccines that prevent H1N1 have been a long-standing void in the treatment algorithm. Therefore, the introduction advanced vaccines in...

  • Influenza
  • World
  • AstraZeneca PLC
  • Novartis AG
  • Sanofi S.A.
  • 20.2 LITHUANIA SEASONAL INFLUENZA VACCINE MARKET
  • Lithuania - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022

One egg is about enough for one dose.

  • Influenza
  • Vaccine
  • Northern Europe
  • Forecast
  • Market Size
  • Forecast
  • Forecast

Indonesia ##.

  • Influenza
  • World
  • Forecast
  • Market Size
  • Sanofi S.A.

India, with an average ##. ## hospital beds per ##, ## of its population, has a patchy public health care system with underfunded hospitals and clinics, and ineffective health-related schemes.

  • Influenza
  • Vaccine
  • Southern Europe
  • Forecast
  • Market Size

Figure ##-##: Worldwide - Hospital Beds (Number) per Thousand, 2014 - 2019 Life-course vaccination against tetanus and diphtheria received high governmental support (## countries cover the cost of vaccination totally or partially).

  • Influenza
  • Vaccine
  • Eastern Europe
  • Forecast
  • Market Size
  • 7.2 Lithuania Seasonal Influenza Vaccine Market Analysis
  • Lithuania - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022

India, with an average ##. ## hospital beds per ##, ## of its population, has a patchy public health care system with underfunded hospitals and clinics, and ineffective health-related schemes.

  • Healthcare
  • Influenza
  • Baltics
  • Northern Europe
  • Market Size
  • 5.1 Denmark Seasonal Influenza Vaccinated Total Population

Figure ##-##: Worldwide - Hospital Beds (Number) per Thousand, 2014 - 2019 Life-course vaccination against tetanus and diphtheria received high governmental support (## countries cover the cost of vaccination totally or partially).

  • Influenza
  • Vaccine
  • Northern Europe
  • Forecast
  • Market Size
  • INFLUENZA SYMPTOMS
  • ILLUSTRATES THE CLINICAL PRESENTATION OF PATIENTS WITH INFLUENZA INFECTION.

PLOS ONE; ##(##): E##.

  • Influenza
  • Market Size
  • CSL Limited
  • Daiichi Sankyo Company
  • Mitsubishi Corporation

One egg is about enough for one dose.

  • Influenza
  • Vaccine
  • Western Europe
  • Forecast
  • Market Size
  • Lithuania - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
  • 19.2 LITHUANIA SEASONAL INFLUENZA VACCINE MARKET

One egg is about enough for one dose.

  • Influenza
  • Vaccine
  • Northern Europe
  • Forecast
  • Market Size

(c) AZOTH Analytics ##.

  • Influenza
  • World
  • Market Size
  • Emergent BioSolutions Inc.
  • Sanofi S.A.
  • Forecast

If small children are affected, they also might need hospital care but deaths are rare.

  • Influenza
  • Market Size
  • MedImmune, LLC
  • Novartis AG
  • Sanofi S.A.

STRENGTH: ## LOW; ## HIGH F.

  • Influenza
  • Bristol-Myers Squibb Company
  • Gilead Sciences, Inc.
  • GlaxoSmithKline plc
  • ViiV Healthcare Ltd.
  • Forecast
  • FORECAST

Price rises of several hundred yen are planned at many hospitals.

  • Influenza
  • Market Size
  • MedImmune, LLC
  • Novartis AG
  • Sanofi S.A.

Global Influenza Diagnostics Market Analysis & Trends - Industry Forecast to 2025 ## Market Outline ##. ## Research Methodology ##. ##. ## Research Approach & Sources ##. ## Market Trends ##. ## Regulatory Factors ##. ## End User Analysis ##. ## Strategic Benchmarking ##. ## Opportunity Analysis ## Executi

  • Diagnostics
  • Influenza
  • United States
  • Forecast
  • Market Size
  • 4.2 GROWTH DRIVERS

Pain when one moves eyes.

  • Influenza
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Novartis AG
  • Sanofi S.A.
  • Forecast
  • Forecast

Price rises of several hundred yen are planned at many hospitals.

  • Influenza
  • Forecast
  • Market Size
  • Novartis AG
  • Sanofi S.A.
  • Seasonal Influenza Therapeutics Market, Japan, Treatment Patterns (million), 2015-2022
  • 2.5 DIAGNOSIS

The cost of vaccines in hospitals and clinics is also different.

  • Influenza
  • World
  • Market Size
  • Daiichi Sankyo Company
  • Sanofi S.A.

The report provides test volume and sales forecasts by country and market segment, including:& nbsp; & nbsp; & nbsp; & nbsp; - Hospitals& nbsp; & nbsp; & nbsp; & nbsp; - Commercial/ Private Labs& nbsp; & nbsp; & nbsp; & nbsp; - Physician Offices& nbsp; &

  • Influenza
  • Europe
  • Japan
  • United States
  • Demand
  • 2.3.2 Laboratory Confirmed Influenza Cases
  • Risk Factors and Comorbidities for Seasonal Influenza

GBR Kompakt; ##: ##-##.

  • Influenza
  • Germany
  • Japan
  • United States
  • Forecast

Hospitals held the highest market share in 2015, but Point-of-Care Testing (POCT) is anticipated to overtake and lead the market in the coming future, owing to the increasing usage of POCT because of its ease of use and short turnaround times.

  • Diagnostics
  • Influenza
  • United States
  • Demand
  • Market Size

The report provides test volume and sales forecasts by country and market segment, including:& nbsp; & nbsp; & nbsp; & nbsp; - Hospitals& nbsp; & nbsp; & nbsp; & nbsp; - Commercial/ Private Labs& nbsp; & nbsp; & nbsp; & nbsp; - Physician Offices& nbsp; &

  • Infectious Disease
  • Influenza
  • Respiratory Disease
  • Europe
  • Demand

Influenza vaccines

4546 5000 3864

" There is only one quadrivalent vaccine licensed by only one company, so it is hardly available on the market.

  • Influenza
  • United States
  • Forecast
  • Novavax, Inc.
  • Sanofi S.A.
  • HOSPITALS/CLINICAL LABORATORIES TO DOMINATE THE INFLUENZA
  • INFLUENZA DIAGNOSTICS MARKET SIZE FOR HOSPITALS/CLINICAL LABORATORIES, BY REGION, 2014-2021 (USD MILLION)

The global influenza diagnostics market is expected to reach USD 767.4 million by 2021 from USD 508.0 million in 2016, at a CAGR of 8.6% from 2016 to 2021. On the basis of test type, the market is segmented into traditional and molecular diagnostic tests. The traditional diagnostic tests segment is further categorized into rapid influenza...

  • Influenza
  • North America
  • United States
  • Market Size
  • Alere Inc.

Hospitals ##. ##. ##.

  • Influenza
  • Pathology
  • APAC
  • World
  • Company Financials
  • Clinical Trial profile. 42 Trial Title
  • Clinical Trial profile. 39 Trial Title

Hoffmann-La Roche Ltd Microgen Scientific Industrial Company for Immunobiological ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## Medicines ## ## ## ## ## ## ## ## Altimmune Inc ## ## ## ## ## ## ## ## CSL Ltd Source: GlobalData' s Pharma Intelligence Center C

  • Drug Discovery And Development
  • Influenza
  • World
  • Product Initiative
  • GlaxoSmithKline plc